Living up to its moniker of a defensive bet, the Rs 2.8 lakh crore Indian pharmaceutical sector is set to emerge more or less unscathed from the Covid-19 pandemic this fiscal, rating agency Crisil has stated. "The sector is well-diversified with
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/367BFSA
from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/367BFSA